ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01119105
Recruitment Status : Completed
First Posted : May 7, 2010
Last Update Posted : July 4, 2012
Sponsor:
Information provided by (Responsible Party):
Nabriva Therapeutics AG

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2010
  Actual Study Completion Date : March 2011
  Certification/Extension First Submitted : June 5, 2012